Pharmacoepidemiology & Pharmacovigilance by Distance Learning
Course
Distance
Description
-
Type
Course
-
Level
Intermediate
-
Methodology
Distance Learning
-
Duration
Flexible
-
Start date
Different dates available
-
Online campus
Yes
-
Delivery of study materials
Yes
-
Support service
Yes
-
Virtual classes
Yes
The global challenge of maximising drug safety yet maintaining public confidence has become increasingly complex. Health authorities are tasked to provide quality care while managing a growing drug budget. Regulatory authorities must balance the potential benefits of new drugs with the perception of their potential harm.
This Postgraduate Professional Development Short Course addresses the need for well-informed professionals to work in all areas related to the assessment of drug safety and the management of risks and benefits of medications, including vaccines.
This course is run in collaboration with University of London, and applications must be made via the University of London website.
Facilities
Location
Start date
Start date
About this course
By the end of this course, you will be able to:
Demonstrate an understanding and critically evaluate issues surrounding the risks and benefits of drug use in humans including the cause, manifestations and consequences of adverse drug effects (ADEs), the manner in which these are detected and monitored, and the related historic and legal frameworks
Understand and critically compare fundamental statistical, economic and epidemiological concepts and methods
Understand and critically reflect upon important pharmacoepidemiological concepts and methods and how these methods can be applied to specific drug issues
Assess and critically analyse the results of pharmacoepidemiological studies, including critical appraisal of the study question, study design, methods and conduct, statistical analyses and interpretation
Understand how new medicines are assessed for their cost-effectiveness as well as efficacy and safety, before being recommended for use
Apply the techniques and approaches covered in the taught element of the course, plus your own experience, to evaluate issues presented to you in the format of a project, and where relevant, develop recommendations for the best option or options
This course is aimed at personnel involved in the safe use of medicines, particularly in developed countries. This includes those working (or intending to work) in: the pharmaceutical industry who are involved in drug development, licensing and surveillance; regulatory bodies who are involved in licensing and surveillance; the health service who are involved in drug policy; and health policy decision-making agencies.
Reviews
Subjects
- Benefits
- Quality Training
- Quality
- Global
- University
- Project
- Underpinning
- Determining
- Pharmacoepidemiology
- Large
- Statistical
Course programme
Pharmacoepidemiology - you will learn about the fundamentals of pharmacoepidemiology, its conduct, practical uses and limitations in determining the effects of medications in large groups of people. The statistical basis underpinning pharmacoepidemiology will also be introduced, and you will integrate statistics and epidemiology to gain competence in critically appraising pharmacoepidemiology studies.
Pharmacovigilance - you will be introduced to the key elements of pharmacovigilance and its basis within drug regulation. Within the risk management elements of the course, you will gain insight into how pharmacoepidemiology and pharmacovigilance are combined in the investigation of the effects of medicines. Principles will largely be demonstrated within the European legislative context, whilst recognizing these general principles apply more broadly throughout the world.
Health economics - you will be introduced to the fundamental concepts involved in assessing the cost effectiveness of health technologies and methodologies used to assess the health related quality of life. Real world examples will be used to illustrate concepts.
ProjectAn integrating project will enable you to demonstrate your global understanding of pharmacoepidemiology and pharmacovigilance.
Comprehensive learning materialsYour materials are provided via a dedicated virtual learning environment. These include:
- Fully interactive self-directed sessions on each topic
- Audio and video case studies
- A compendium of resources, including relevant papers and reports
- Access to the University of London and LSHTM online library resources
Students may choose to attend a week of lectures at LSHTM in November (dates for 2019 are 4-7 November), which are part of the face-to-face version of the Pharmacoepidemiology and Pharmacovigilance course held in London. Those wishing to do so must apply directly to LSHTM by completing the online application form for the face-to-face programme (an additional fee of £500 will apply).
Tutorial supportStaff involved in the on-campus course at LSHTM will support this course between the beginning of November and the end of May. You’ll also be allocated a personal advisor who will advise on your project.
Networking opportunitiesThough much of the work is by self-directed learning, you are encouraged to take part in module-specific discussions and real-time tutorials available on the virtual learning environment.
Time commitmentThe anticipated time required to complete the course is 300 study hours - roughly 100 of which will be dedicated to the project.
Quality assuranceLSHTM is a highly respected world leader in this field. This course is established on-campus and is moderated annually by an exam board and an external examiner.
Pharmacoepidemiology & Pharmacovigilance by Distance Learning